Due: September 14, 2026 ASPR IBMSC is seeking to establish vendor managed inventory (VMI) capabilities for active pharmaceutical ingredients (APIs) used in medical countermeasure finished dose form (FDF) drug products. This scope includes providing a Read More
Due: September 8, 2026 ASPR IBMSC is seeking to expand the domestic manufacturing capacity of nitrile gloves. This capacity expansion is essential to ensure sufficient nitrile gloves availability in response to surge demand during future Read More
Due: September 8, 2026 ASPR IBMSC is seeking to support production capacity for nitrile butadiene rubber (NBR) in support of personal protective equipment (PPE), specifically nitrile gloves manufacturing. This includes maintaining the necessary capacity for Read More
Due: September 10, 2026 The fiscal year 2026 (FY26) Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) supports promising research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system Read More
Due: September 7, 2026 The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer’s disease (AD) Read More
Due: September 7, 2026 Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or Read More
Due: September 7, 2026 The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics Read More
Due: September 7, 2026 Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational Read More
Due: September 7, 2026 Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory Read More
Due: September 7, 2026 This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.